Una iniciativa piloto permitirá por primera vez que millones de beneficiarios accedan a fármacos GLP-1 para tratar la obesidad con un copago mensual de 50 dólares

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

Popular Novo Nordisk and Eli Lilly drugs are included

Popular Novo Nordisk and Eli Lilly drugs are included

Medicare enrollees as of July 1 can get GLP-1s covered by Part D prescription insurance as part of a trial program until the end of 2027.